Lead Trainer, Fluence
Clinical Assistant Professor of Psychiatry, NYU School of Medicine
Jeffrey Guss, MD is a psychiatrist, psychoanalyst, researcher and teacher with specializations in psychoanalytic therapy and psychedelic therapy. He was Co-Principal Investigator and Director of Psychedelic Therapy Training for the NYU School of Medicine’s study on psilocybin-assisted psychotherapy in the treatment of cancer related existential distress, published in Journal of Psychopharmacology, 2016.
He currently a Lead Trainer with Fluence, with a focus on the integration of psychedelic therapy with psychoanalysis. He is a study therapist in the NYU study on Psilocybin-Assisted treatment of Major Depressive Disorder, and published on the integration of Acceptance and Commitment Therapy with psychedelic assisted therapy for MDD in Journal of Contextual and Behavioral Science.
Jeff is interested in the integration of psychedelic therapies with contemporary psychoanalytic theory and has published in Studies in Gender and Sexuality and Psychoanalysis, Culture and Society. He co-authored a paper on the influence of therapists’ first hand experience with psychedelics on psychedelic-assisted psychotherapy research in The Journal of Psychedelic Studies. He is an Instructor and Mentor with the California Institute of Integral Studies’ Center for Psychedelic Therapies.
He maintains a private practice in New York City.